![](/img/cover-not-exists.png)
EZH2 overexpression in myeloma patients shortens survival and in-vitro data supports a potential new targeted treatment strategy
Pawlyn, C., Kaiser, M., Buros, A., Stein, C., Macleod, V., Mirabella, F., Fok, J., Jones, J., Edmondson, R., Barlogie, B., Walker, B., Morgan, G., Davies, F.Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2015.07.461
Date:
September, 2015
File:
PDF, 56 KB
english, 2015